SQZ Biotechnologies Company
SQZ was delisted on the 3rd of July, 2023.
5 hedge funds and large institutions have $333K invested in SQZ Biotechnologies Company in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 26 closing their positions.
84% less funds holding
Funds holding: 31 → 5 (-26)
89% less capital invested
Capital invested by funds: $2.96M → $333K (-$2.63M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 26
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Temasek Holdings
Singapore
|
-$745K |
| 2 |
MC
Maverick Capital
Dallas,
Texas
|
-$284K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$254K |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$230K |
| 5 |
LCM
Laurion Capital Management
New York
|
-$111K |
SQZ Hedge Fund Activity: Q3 2023 in Review
5 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in SQZ Biotechnologies Company (SQZ) for Q3 2023, worth a combined $333K — down 89% from $2.96M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of SQZ and 0 opened new positions — a net loss of 26 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Temasek Holdings, exiting entirely with an estimated $745K sold.
- 5 institutional investors held SQZ Biotechnologies Company (SQZ) as of Q3 2023, down from 31 in Q2 2023.
- Funds reported $333K of SQZ Biotechnologies Company stock for Q3 2023, down 89% quarter-over-quarter.
- 0 funds opened new SQZ Biotechnologies Company positions in Q3 2023 and 26 closed out, a net change of -26 holders.
- The largest SQZ Biotechnologies Company seller in Q3 2023 was Temasek Holdings, an estimated $745K sold.
Based on aggregated 13F filings for Q3 2023.